株探米国株
日本語 英語
エドガーで原本を確認する
0001443669FALSE00014436692025-10-312025-10-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 31, 2025
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 001-35435 41-1939628
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification Number)
5540 Pioneer Creek Drive
Maple Plain, Minnesota
55359
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(763) 479-3680
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02. Results of Operations and Financial Condition.
On October 31, 2025, Proto Labs, Inc. issued a press release announcing its third quarter 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
99.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:
October 31, 2025
By: /s/ Daniel Schumacher
Daniel Schumacher
Chief Financial Officer

EX-99.1 2 prlb-20251031xexx991.htm EX-99.1 Document

Exhibit 99.1
logo.jpg
logo1.jpg
Protolabs Reports Financial Results for the Third Quarter of 2025
Record Quarterly Revenue of $135.4 Million, a 7.8% increase Year-Over-Year
GAAP Earnings Per Share of $0.30, Non-GAAP Earnings Per Share of $0.47
MINNEAPOLIS – October 31, 2025 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights:
•Revenue was a record $135.4 million, a 7.8% increase compared to revenue of $125.6 million in the third quarter of 2024.
•Revenue fulfilled through digital factories was $105.3 million, a 4.9% increase year-over-year.
•Revenue fulfilled through the Protolabs Network was $30.1 million, a 19.1% increase year-over-year.
•Net income was $7.2 million, or $0.30 per diluted share, compared to $7.2 million, or $0.29 per diluted share, in the third quarter of 2024.
•Non-GAAP net income was $11.4 million, or $0.47 per diluted share, compared to $11.8 million, or $0.47 per diluted share, in the third quarter of 2024. See “Non-GAAP Financial Measures” below.

“Protolabs generated another quarter of accelerated growth and record revenue, supported by strong performance in several key end markets, and a substantial increase in revenue per customer contact. I am very encouraged by the progress we’ve made over the last two quarters—we have significant momentum into year-end," commented President and Chief Executive Officer Suresh Krishna. "While it’s still early, my short time here has strengthened my confidence that our current strategy—delivering high-quality, custom parts throughout the product lifecycle, from prototyping to production—is the right one. Together with our teams, I am focused on accelerating profitable growth, and positioning Protolabs for long-term shareholder value creation."

Dan Schumacher, Chief Financial Officer, added: "Along with record revenue in the quarter, we continued to demonstrate the strength of our business model by expanding adjusted EBITDA as compared to the second quarter of 2025, continuing our best-in-class cash flow generation, and returning capital to shareholders via repurchases of common stock."

Additional Third Quarter 2025 Highlights:
•Customer contact information
◦Protolabs served 21,252 customer contacts during the quarter.
◦Revenue per customer contact increased 14.1% year-over-year to $6,370.
•EBITDA was $17.4 million. See “Non-GAAP Financial Measures” below.
•Adjusted EBITDA was $21.1 million, or 15.6% of revenue. See "Non-GAAP Financial Measures" below.
•We generated $29.1 million in cash from operations.
•Cash and investments balance was $138.4 million as of September 30, 2025.

Fourth Quarter 2025 Outlook

In the fourth quarter of 2025, the Company expects to generate revenue between $125.0 million and $133.0 million.

The Company expects fourth quarter 2025 diluted net income per share between $0.12 and $0.20, and non-GAAP diluted net income per share between $0.30 and $0.38. See "Non-GAAP Financial Measures" below.



Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, CEO transition costs and costs related to exit and disposal activities (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by service line, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company’s business, and in determining executive and senior management incentive compensation. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.
Conference Call
The Company has scheduled a conference call to discuss its third quarter 2025 financial results and fourth quarter 2025 outlook today, October 31, 2025 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/mp2aa5du/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.
About Protolabs
Protolabs is the world’s fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey. Get started now at protolabs.com.



Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Source: Proto Labs, Inc.

Investor Relations Contacts:
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and Corporate Development
ryan.johnsrud@protolabs.com

Gateway Group, Inc.
949-574-3860
PRLB@gateway-grp.com
Media Contact:
Protolabs
Brent Renneke, 763-479-7704
Marketing Communications Manager
brent.renneke@protolabs.com



Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
September 30,
2025
December 31,
2024
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 104,422  $ 89,071 
Short-term marketable securities 14,817  14,019 
Accounts receivable, net 77,790  66,504 
Inventory 14,073  12,305 
Income taxes receivable 4,681  2,906 
Prepaid expenses and other current assets 10,009  10,049 
Total current assets 225,792  194,854 
Property and equipment, net 211,325  227,263 
Goodwill 273,991  273,991 
Other intangible assets, net 19,539  21,422 
Long-term marketable securities 19,149  17,773 
Operating lease assets 2,015  2,993 
Finance lease assets 491  692 
Other long-term assets 4,553  4,524 
Total assets $ 756,855  $ 743,512 
Liabilities and shareholders' equity    
Current liabilities    
Accounts payable $ 17,388  $ 15,504 
Accrued compensation 23,268  16,550 
Accrued liabilities and other 27,831  19,621 
Current operating lease liabilities 890  1,287 
Current finance lease liabilities 365  309 
Total current liabilities 69,742  53,271 
Long-term operating lease liabilities 1,188  1,633 
Long-term finance lease liabilities —  287 
Long-term deferred tax liabilities 16,038  13,565 
Other long-term liabilities 5,168  4,605 
Shareholders' equity 664,719  670,151 
Total liabilities and shareholders' equity $ 756,855  $ 743,512 



Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Revenue
Injection Molding $ 47,770  $ 46,831  $ 143,908  $ 148,574 
CNC Machining 63,043  53,327  177,831  154,498 
3D Printing 20,082  21,437  61,491  64,300 
Sheet Metal 4,262  3,743  12,776  11,218 
Other Revenue 209  281  628  550 
Total Revenue 135,366  125,619  396,634  379,140 
Cost of revenue 74,073  68,389  219,869  207,897 
Gross profit 61,293  57,230  176,765  171,243 
Operating expenses
Marketing and sales 24,574  22,619  73,054  69,070 
Research and development 10,705  9,772  32,487  31,600 
General and administrative 17,163  16,259  52,763  49,167 
Costs related to exit and disposal activities 41  —  151  — 
Total operating expenses 52,483  48,650  158,455  149,837 
Income from operations 8,810  8,580  18,310  21,406 
Other income, net 1,441  1,288  4,600  3,548 
Income before income taxes 10,251  9,868  22,910  24,954 
Provision for income taxes 3,035  2,679  7,668  7,957 
Net income $ 7,216  $ 7,189  $ 15,242  $ 16,997 
Net income per share:
Basic $ 0.30  $ 0.29  $ 0.64  $ 0.67 
Diluted $ 0.30  $ 0.29  $ 0.63  $ 0.67 
Shares used to compute net income per share:
Basic 23,889,157 24,980,536 23,974,054 25,304,985
Diluted 24,191,039 25,022,485 24,249,669 25,382,280



Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
2025 2024
Operating activities
Net income $ 15,242  $ 16,997 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 25,693  26,984 
Stock-based compensation expense 11,928  12,716 
Deferred taxes 2,355  (6,140)
Interest on finance lease obligations 16  26 
Loss on impairment of equipment —  256 
Impairments related to exit and closure of facilities 448  — 
Loss (gain) on disposal of property and equipment 16  (24)
Other (179) 103 
Changes in operating assets and liabilities 2,534  9,617 
Net cash provided by operating activities 58,053  60,535 
Investing activities
Purchases of property, equipment and other capital assets (6,792) (8,339)
Proceeds from sales of property, equipment and other capital assets 811  34 
Purchases of marketable securities (13,553) (18,087)
Proceeds from call redemptions and maturities of marketable securities 11,730  15,709 
Net cash used in investing activities (7,804) (10,683)
Financing activities
Proceeds from issuance of common stock from equity plans 4,195  2,094 
Purchases of shares withheld for tax obligations (3,119) (1,920)
Repurchases of common stock (36,732) (45,958)
Principal repayments of finance lease obligations (231) (220)
Net cash used in financing activities (35,887) (46,004)
Effect of exchange rate changes on cash and cash equivalents 989  235 
Net increase in cash and cash equivalents 15,351  4,083 
Cash and cash equivalents, beginning of period 89,071  83,790 
Cash and cash equivalents, end of period $ 104,422  $ 87,873 



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities
GAAP net income $ 7,216  $ 7,189  $ 15,242  $ 16,997 
Add back:
Stock-based compensation expense 3,677  4,196  11,928  12,716 
Amortization expense 935  888  2,770  2,796 
Unrealized (gain) loss on foreign currency (2) 174  (316) 323 
CEO transition costs 14  —  1,376  — 
Costs related to exit and disposal activities 41  —  151  — 
Total adjustments 1
4,665  5,258  15,909  15,835 
Income tax benefits on adjustments 2
(500) (627) (1,700) (1,066)
Non-GAAP net income $ 11,381  $ 11,820  $ 29,451  $ 31,766 
Non-GAAP net income per share:
Basic $ 0.48  $ 0.47  $ 1.23  $ 1.26 
Diluted $ 0.47  $ 0.47  $ 1.21  $ 1.25 
Shares used to compute non-GAAP net income per share:
Basic 23,889,157 24,980,536 23,974,054 25,304,985
Diluted 24,191,039 25,022,485 24,249,669 25,382,280
1Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Cost of revenue $ 781  $ 817  $ 2,350  $ 2,428 
Marketing and sales 837  727  2,423  2,378 
Research and development 764  671  2,124  2,031 
General and administrative 2,244  2,869  9,177  8,675 
Costs related to exit and disposal activities 41  —  151  — 
Total operating expenses 3,886  4,267  13,875  13,084 
Other income, net (2) 174  (316) 323 
Total adjustments $ 4,665  $ 5,258  $ 15,909  $ 15,835 
2For the three and nine months ended September 30, 2025 and 2024, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the respective period.



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Revenue $ 135,366  $ 125,619  $ 396,634  $ 379,140 
Gross profit 61,293  57,230  176,765  171,243 
GAAP gross margin 45.3 % 45.6 % 44.6 % 45.2 %
Add back:    
Stock-based compensation expense 439  474  1,323  1,401 
Amortization expense 342  343  1,027  1,027 
Total adjustments 781  817  2,350  2,428 
Non-GAAP gross profit $ 62,074  $ 58,047  $ 179,115  $ 173,671 
Non-GAAP gross margin 45.9 % 46.2 % 45.2 % 45.8 %



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Revenue $ 135,366  $ 125,619  $ 396,634  $ 379,140 
Income from operations 8,810  8,580  18,310  21,406 
GAAP operating margin 6.5 % 6.8 % 4.6 % 5.6 %
Add back:
Stock-based compensation expense 3,677  4,196  11,928  12,716 
Amortization expense 935  888  2,770  2,796 
CEO transition costs 14  —  1,376  — 
Costs related to exit and disposal activities 41  —  151  — 
Total adjustments 4,667  5,084  16,225  15,512 
Non-GAAP income from operations $ 13,477  $ 13,664  $ 34,535  $ 36,918 
Non-GAAP operating margin 10.0 % 10.9 % 8.7 % 9.7 %



Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Revenue $ 135,366  $ 125,619  $ 396,634  $ 379,140 
GAAP net income 7,216  7,189  15,242  16,997 
GAAP net income margin 5.3 % 5.7 % 3.8 % 4.5 %
Add back:
Amortization expense $ 935  $ 888  $ 2,770  $ 2,796 
Depreciation expense 7,494  8,021  22,923  24,188 
Interest income, net (1,281) (1,287) (3,532) (3,548)
Provision for income taxes 3,035  2,679  7,668  7,957 
EBITDA 17,399  17,490  45,071  48,390 
EBITDA Margin 12.9 % 13.9 % 11.4 % 12.8 %
Add back:
Stock-based compensation expense 3,677  4,196  11,928  12,716 
Unrealized (gain) loss on foreign currency (2) 174  (316) 323 
CEO transition costs 14  —  1,376  — 
Costs related to exit and disposal activities 41  —  151  — 
Total adjustments 3,730  4,370  13,139  13,039 
Adjusted EBITDA $ 21,129  $ 21,860  $ 58,210  $ 61,429 
Adjusted EBITDA Margin 15.6 % 17.4 % 14.7 % 16.2 %



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2025
Three Months Ended
September 30, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 109,361  $ —  $ 109,361  $ 99,571  9.8 % 9.8 %
Europe 26,005  (1,226) 24,779  26,048  (0.2) (4.9)
Total revenue $ 135,366  $ (1,226) $ 134,140  $ 125,619  7.8 % 6.8 %
Nine Months Ended
September 30, 2025
Nine Months Ended
September 30, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 320,340  $ —  $ 320,340  $ 299,593  6.9 % 6.9 %
Europe 76,294  (2,055) 74,239  79,547  (4.1 %) (6.7 %)
Total revenue $ 396,634  $ (2,055) $ 394,579  $ 379,140  4.6 % 4.1 %

1Revenue for the three and nine months ended September 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2024 to GAAP revenue for the three and nine months ended September 30, 2025.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2024 to non-GAAP revenue for the three and nine months ended September 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2024) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2025
Three Months Ended
September 30, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 47,770  $ (358) $ 47,412  $ 46,831  2.0 % 1.2 %
CNC Machining 63,043  (667) 62,376  53,327  18.2  17.0 
3D Printing 20,082  (174) 19,908  21,437  (6.3) (7.1)
Sheet Metal 4,262  (23) 4,239  3,743  13.9  13.3 
Other Revenue 209  (4) 205  281  (25.6) (27.0)
Total revenue $ 135,366  $ (1,226) $ 134,140  $ 125,619  7.8 % 6.8 %
Nine Months Ended
September 30, 2025
Nine Months Ended
September 30, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 143,908  $ (706) $ 143,202  $ 148,574  (3.1 %) (3.6 %)
CNC Machining 177,831  (981) 176,850  154,498  15.1  14.5 
3D Printing 61,491  (336) 61,155  64,300  (4.4) (4.9)
Sheet Metal 12,776  (30) 12,746  11,218  13.9  13.6 
Other Revenue 628  (2) 626  550  14.2  13.8 
Total revenue $ 396,634  $ (2,055) $ 394,579  $ 379,140  4.6 % 4.1 %

1Revenue for the three and nine months ended September 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2024 to GAAP revenue for the three and nine months ended September 30, 2025.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2024 to non-GAAP revenue for the three and nine months ended September 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2024) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025 2024 2025 2024
Revenue $ 135,366  $ 125,619  $ 396,634  $ 379,140 
Customer contacts 21,252 22,511 41,873 43,671
Revenue per customer contact1
$ 6,370  $ 5,580  $ 9,472  $ 8,682 

1Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)

Q4 2025 Outlook
Low High
GAAP diluted net income per share $ 0.12  $ 0.20 
Add back:
Stock-based compensation expense 0.14  0.14 
Amortization expense 0.03  0.03 
Unrealized (gain) loss on foreign currency 0.00  0.00 
Total adjustments 0.18  0.18 
Non-GAAP diluted net income per share $ 0.30  $ 0.38